ASTRAZENECA TAD INEFFECTIVE AGAINST SOUTH AFRICAN CORONAVIRUS VARIANT

• The world is caught between two poles one being a race with spread of coronavirus variants and the other being inoculating millions.
•  AstraZeneca candidly announced Saturday that early data shows its vaccine has restricted potential and hence limited protection against mild disease caused by the South African variant of the virus.

The test group was a small motley group, about 2,000 people, and young, ....